Back to Graphic Version

SAMHSA News - Volume XI, Number 1, Winter 2003
 

SAMHSA Launches Buprenorphine Education Initiative

(Related Content)

Recognizing Signs of Drug Abuse


Many physicians have never treated patients addicted to heroin or other injection drugs, according to Robert Lubran, M.S., M.P.A., Director of the Division of Pharmacologic Therapies at SAMHSA's Center for Substance Abuse Treatment (CSAT). As a result, they may miss key signs of drug abuse.

To help physicians and other health care professionals make accurate diagnoses, CSAT developed a new tool, Classifying Skin Lesions of Injection Drug Users: A Method for Corroborating Disease Risk. The publication-a series of laminated photocards grouped together by a metal ring-helps health care professionals determine whether lesions are the result of recent injection drug use, past use, or some other cause.

To order a free copy, contact SAMHSA's National Clearinghouse for Alcohol and Drug Information at P.O. Box 2345, Rockville, MD 20847-2345. Telephone: 1 (800) 729-6686 (English and Spanish) or (301) 468-2600; TDD 1 (800) 487-4889. Or visit SAMHSA's Web site, www.csat.samhsa.gov.

Back to Top



SAMHSA Home | Back to Graphic Version | Privacy Statement | Site Disclaimer | Accessibility